Shaping the Future of Cannabis.

About

Background Vision

ECH is a London based venture builder focused on building the medical cannabis market in Europe - we build, invest or partner with companies in this space.

We have a fast growing portfolio of private companies that focus on ancillary products to the medical cannabis sector, across three key pillars; Platforms, Brands and Access. These are the areas that we believe will shape the future of the industry across Europe.

Our operational expertise in starting and growing business in the medical cannabis space is second to none. And, our global network and knowledge gives our portfolio the very best chance to perform at the absolute best of their ability.

As the medical cannabis industry opens and talent and new businesses pour in, ECH is ideally placed to work with the very best and achieve huge success across the eco system.

ECH is an unrivalled group of companies at the forefront of the European market – we provide venture capital, exceptional talent and operational excellence. We build the platforms and brands that will shape the industry for years to come.

We have a fast growing portfolio of private companies that focus on ancillary products to the medical cannabis sector, across three key pillars; Platforms, Brands and Access. These are the areas that we believe will shape the future of the industry across Europe.

We are all known to influence and drive sustained scalable and profitable change. And, our global network and knowledge gives our portfolio the very best chance to perform at the absolute best of their ability.

As the medical cannabis industry opens and talent and new businesses pour in, ECH is ideally placed to work with the very best and achieve huge success across the eco system.

Driving leadership, innovation and growth in Europe’s cannabis industry, we are an unrivalled group of companies at the forefront of the market. Our brands are well known and instrumental in driving sustained, scalable and profitable change.

Shaping the future of cannabis.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Hoc est non dividere, sed frangere. Quae sequuntur igitur? Tria genera bonorum; Quae ista amicitia est? Duo Reges: constructio interrete. Sed haec in pueris; Sed fortuna fortis; Negat esse eam, inquit, propter se expetendam.

Est enim effectrix multarum et magnarum voluptatum. Praeclarae mortes sunt imperatoriae; Omnia contraria, quos etiam insanos esse vultis. Cur id non ita fit?

Ecce aliud simile dissimile. Videmus igitur ut conquiescere ne infantes quidem possint. Verum hoc idem saepe faciamus. Oratio me istius philosophi non offendit; Tum ille: Ain tandem? Non potes, nisi retexueris illa.

Et non ex maxima parte de tota iudicabis? Easdemne res? Itaque ab his ordiamur. An hoc usque quaque, aliter in vita? Quid est igitur, inquit, quod requiras?

Vision

ECH is on a mission to shape the future of cannabis.

We are building the infrastructure that will make cannabis more readily acceptable and accessible. 

We have identified gaps in the emerging market and invest in developing assets with significant upside potential over the short to medium term.

We provide venture capital, exceptional talent and operational excellence to a fast-growing portfolio of companies.

Read

Read

Read

Read

Read

Read

Prohibition Partners

Overview

Prohibition Partners is the world’s leading provider of market insights and strategic consultancy for the global cannabis industry.

It is on a mission to open up the industry through reliable data and credible intelligence.


Cannabis Europa

Overview

Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe.

It has quickly become Europe’s premier medical cannabis conference, attracting industry leaders from around the world across health, policy, science and investment.


European Cannabis Week

Overview

A week of cannabis events held in London to include diverse programme of politics, science, health, investment, culture and networking.

The first European Cannabis Week will be held w/c 24th June 2019.


The Medical Cannabis Clinic

Overview

Our chain of private UK clinics specialises in innovative cannabis-based therapy and prescription cannabinoids, providing effective care for all patients who currently suffer from conditions for which existing treatments are not effective.

The team is the most experienced and respected group of medical practitioners working with cannabis in the UK including leading experts across Pain, Neurology and Psychiatry.


The Academy of Medical Cannabis

Overview

The Academy of Medical Cannabis is the definitive name in cannabis education for the global healthcare sector.

It features a comprehensive set of online learning modules created by one of the world’s leading experts, Professor Mike Barnes.


Astral Health

Overview

Astral Health is Europe’s end-to-end solution for the import and distribution of medical cannabis.

The team facilitates the licensed import of approved medical cannabis products on an ongoing contractual basis - supported by a range of commercialisation services.


Leadership

Board of Directors

Management Team

Medical Advisory Board

News

ECH Announces Intention To Demerge Group of Com...

25th June 2019

Independent Management and new corporate advisers will reinforce reputation at the forefront of the global cannabis...

Read Article

Medical team of experts ready to launch the UK’...

18th June 2019

London facility will help patients with epilepsy, chronic pain,PTSD and more. World-leading experts in neurology, stroke...

Read Article

ECH Announces Launch of ECH Medical

29th May 2019

New division will focus on building a European ecosystem to improve patient access to medical cannabis...

Read Article

Contact

From:

Telephone:

Subject:

Message Body

This form collects your contact information so that we can correspond with you.Please review our privacy policy for more information about how we protect and manage your data.